Header

UZH-Logo

Maintenance Infos

Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis


Martin, R (2012). Anti-CD25 (daclizumab) monoclonal antibody therapy in relapsing–remitting multiple sclerosis. Clinical Immunology, 142(1):9-14.

Statistics

Citations

Dimensions.ai Metrics
51 citations in Web of Science®
52 citations in Scopus®
82 citations in Microsoft Academic
Google Scholar™

Altmetrics

Downloads

1 download since deposited on 13 Dec 2012
0 downloads since 12 months
Detailed statistics

Additional indexing

Item Type:Journal Article, refereed, further contribution
Communities & Collections:04 Faculty of Medicine > University Hospital Zurich > Clinic for Neurology
Dewey Decimal Classification:610 Medicine & health
Language:English
Date:2012
Deposited On:13 Dec 2012 10:59
Last Modified:17 Feb 2018 00:13
Publisher:Elsevier
Series Name:Clinical Immunology
ISSN:1521-6616
OA Status:Closed
Publisher DOI:https://doi.org/10.1016/j.clim.2011.10.008
PubMed ID:22284868

Download